# FDA Inspection 1033941 - Vitalant - November 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/vitalant/49f7cf1b-ca46-4614-be2c-896c4c990099
Source feed: FDA_Inspections

> FDA Inspection 1033941 for Vitalant on November 17, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1033941
- Company Name: Vitalant
- Inspection Date: 2017-11-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1115248 - 2019-10-24](https://www.keypedia.com/records/fda_inspections/vitalant/8663c56a-25a0-4682-b149-0b8ba8ef28ed)
- [FDA Inspection 968736 - 2016-02-04](https://www.keypedia.com/records/fda_inspections/vitalant/0ef339e7-425d-4418-bd67-46b4bb67e534)
- [FDA Inspection 865480 - 2014-02-06](https://www.keypedia.com/records/fda_inspections/vitalant/498790a6-a5f9-487e-98cc-a087a989459e)
- [FDA Inspection 667212 - 2010-06-16](https://www.keypedia.com/records/fda_inspections/vitalant/155b8b1c-e088-45e6-ac87-e3d90a665efd)

Company: https://www.keypedia.com/companies/vitalant/24601920-2545-4fc4-a650-58d8f441acf5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d